Check out the highlights so far from Infection Control Today at the Healthcare Sterile Processing Association held in Las Vegas, Nevada, from April 20 to April 23, 2024.
Infection Control Today (ICT) is attending the Healthcare Sterile Processing Association (HSPA) Annual Conference in Las Vegas, Nevada, from April 20 to April 23, 2024.
Three articles from the conference so far include:
Streamlining Loaner Equipment Management: A Case Study From Siriraj Piyamaharajkarun Hospital
CSSD at Siriraj Piyamaharajkarun Hospital presents a poster at HSPA 2024, outlining efforts to streamline loaner equipment management for surgical efficiency.
Sterile Processing Technicians: Preparing for Survey
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS, spoke at the HSPA Annual Conference about being survey-ready. Listen to ICT's interview to learn more!
Preventing Surgical Site Infection in the OR: A Comprehensive Approach to Point-of-Use Instrument Care
Lisa Pawlowski, DNP, MSN-Ed, RN, CRMST, presents a poster at the HSPA 2024 Conference highlighting an evidence-based bundle that reduces SSIs by improving post-use instrument care and storage practices.
Managerial Challenges: Setting Boundaries and Priorities in the Workplace
May 3rd 2024Maintaining boundaries can be challenging in a culture of overwork. In this installment of Dear Helpdesk, learn how to communicate effectively with your boss, prioritize your values, and safeguard your work-life balance.
Comprehensive Guide to Lymphedema: Causes, Prevention, and Management Strategies
May 3rd 2024Lymphedema, a chronic condition often stemming from cancer treatments, leads to tissue swelling. Early detection through surveillance programs and proper skincare can prevent complications like infections.
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses
May 2nd 2024Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?